Jamjoom Pharma, founded in 2000, has established itself as a regional leader in the Biotechnology, Health Care, and Pharmaceutical industries. With its headquarters in Saudi Arabia, the company is deeply rooted in its heritage while also embracing a forward-thinking approach to innovation and healthcare excellence.
Jamjoom Pharma operates with a patient-focused ethos, aiming to provide high-quality, reliable medicines to over 36 countries across the Middle East and Africa. The company's commitment aligns with Saudi Vision 2030, as it contributes to national health security and bolsters local content growth through strategic partnerships.
In its latest financial maneuver, Jamjoom Pharma secured a SAR36.20M debt financing investment from Bank of NATIXIS on January 21, 2024. This capital injection underscores investor confidence in Jamjoom Pharma's strategic objectives and its ongoing expansion in the regional pharmaceutical landscape.